Healthy Trucking Association of America, OraSure Technologies and AbbVie Team Up to Launch Hepatitis C Awareness Campaign at

Healthy Trucking Association of America, OraSure Technologies and AbbVie Team 
Up to Launch Hepatitis C Awareness Campaign at The Great
American Trucking Show 
Hepatitis C Prevalence Among Professional Truck Drivers Is More Than
Five Times Higher Than Other Americans 
DALLAS, TX -- (Marketwired) -- 08/14/14 --  The Healthy Trucking
Association of America (HTAA), OraSure Technologies, Inc. (NASDAQ:
OSUR) and AbbVie today announced they have joined forces to launch
Truckers Rolling Against Hepatitis C, a nationwide initiative to
educate truck drivers about the hepatitis C virus (HCV) and encourage
testing among this population. The campaign will kick off at The
Great American Trucking Show (GATS) in Dallas on August 21-23, 2014
and will continue this fall with local HCV testing events across the
country to test at-risk individuals and help prevent serious
consequences from undiagnosed infection. AbbVie is a global,
research-based biopharmaceutical company. OraSure is a leader in the
fight against HCV and a pioneer and market leader in the development
of point of care testing products for infectious diseases. 
The Truckers Rolling Against Hepatitis C campaign comprises several
key initiatives designed to engage drivers to get tested within their
healthcare settings, including truck stop events, employer testing
initiatives and clinics that serve the trucking community. 
During GATS 2014, truck drivers will be invited to visit the Truckers
Rolling Against Hepatitis C campaign booth, #23113, in the Health &
Wellness Pavilion to receive healthcare education about HCV and get
tested. Drivers will be offered testing with OraSure's OraQuick(R)
HCV Rapid Test, the first and only rapid HCV test approved by the FDA
that provides lab accurate results with a fingerstick blood sample in
just 20 minutes.  
"We are dedicated to helping our fellow drivers receive the most
accurate information and care options to keep them healthy and
providing for their families," said Bill Gordon, chief executive
officer of The Healthy Trucking Association of America. "Together,
working with AbbVie and OraSure, we are committed to helping educate
drivers at tradeshows, terminals, truck-stops and wherever else they
are to learn if they are at risk for this treatable disease." 
About 5.2 million people in the U.S. have been exposed to or are
infected with HCV(1) and three out of four don't know they are
infected.(2-4) Baby boomers (adults born between 1945 and 1965) are
five times more likely to have HCV than other adults, according to
the U.S. Centers for Disease Control and Prevention.(2) While 80
percent of patients infected with HCV experience no symptoms,(5) the
virus can still be detected in the blood. Symptoms of chronic HCV can
take 30 years to develop and damage to the liver can silently occur
during this time. When symptoms do appear, it is often a sign of
advanced liver disease. Further progression of advanced liver
cirrhosis can result in liver failure or liver cancer.(6) There are
approximately 3 million truck drivers employed in the United
States(7), and HCV has a significant impact on this population. The
prevalence of HCV among professional truck drivers, many of whom are
members of the baby boomer generation, is 8.5 percent(8) -- more than
five times higher than other Americans. 
"It is our goal that the Truckers Rolling Against Hepatitis C
campaign will increase screening on a broad scale for this at-risk
population segment and enable them to receive care," said Douglas A.
Michels, president and chief executive officer of OraSure
Technologies. "Working with AbbVie, the Healthy Trucking Association
of America and their wellness partners, we will be able to reach more
professional drivers where they work and live, on our nation's
highways." 
To provide additional opportunities for testing, Rolling Strong, the
trucking industry's acknowledged leader in driver wellness, has
invited the Truckers Rolling Against Hepatitis Ccampaign to join its
latest truck-stop wellness tour this fall. With ongoing support from
Freightliner, and a fast-growing client-base within both the trucking
and motor coach sectors, Rolling Strong is dedicated to helping
drivers develop healthier lifestyle choices and alerting them to the
serious health problems that negatively impact the life expectancy of
professional drivers. 
About the Healthy Trucking Association of America (HTAA) 
The Healthy Trucking Association of America is a non-profit
organization that works with other industry leading wellness
organizations to deliver educational resources and programs to
improve the health of professional drivers. The mission of the
Healthy Trucking Association of America is promoted via multiple
lines of communication, including representation at all major
transportation trade shows, their annual Healthy Trucking Summit, an
interactive website and participation on wellness tours. To learn how
you can get involved with the Healthy Trucking Association of America
please call 800-800-1198 or visit www.healthytruckingassociation.org. 
About OraSure Technologies 
OraSure Technologies is a leader in the development, manufacture and
distribution of point of care diagnostic and collection devices and
other technologies designed to detect or diagnose critical medical
conditions. Its innovative products include rapid tests for the
detection of antibodies to HIV and HCV at the point of care and tests
for various drugs of abuse. The Company sells the OraQuick(R) In-Home
HIV Test, the first and only rapid HIV test approved by the U.S. Food
and Drug Administration for sale to the consumer over-the-counter
market in the U.S. In addition, the Company is a leading provider of
oral fluid sample collection, stabilization and preparation products
for molecular diagnostic applications. OraSure's portfolio of
products is sold globally to various clinical laboratories,
hospitals, clinics, community-based organizations and other public
health organizations, research and academic institutions,
distributors, government agencies, physicians' offices, and
commercial and industrial entities. The Company's products enable
healthcare providers to deliver critical information to patients,
empowering them to make decisions to improve and protect their
health. For more information on OraSure Technologies, please visit
www.orasure.com. 
About AbbVie 
AbbVie is a global, research-based biopharmaceutical company formed
in 2013 following separation from Abbott Laboratories. The company's
mission is to use its expertise, dedicated people and unique approach
to innovation to develop and market advanced therapies that address
some of the world's most complex and serious diseases. AbbVie employs
approximately 25,000 people worldwide and markets medicines in more
than 170 countries. For further information on the company and its
people, portfolio and commitments, please visit www.abbvie.com.
Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn
page. 
1. Chak E, Talal AH, Sherman KE, Schiff ER, Saab S. Hepatitis C
infection in the USA: an estimate of true prevalence. Liver Int.
2011;31:1090-1101. 
2. Centers for Disease Control and Prevention (CDC). Recommendation
for the identification of chronic hepatitis C virus infection among
persons born during 1945-1965. MMWR. 2012;61(4):1-34.
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6104a1.htm. Accessed July
2014. 
3. Centers for Disease Control and Prevention (CDC). Vital signs:
hepatitis C.
http://www.cdc.gov/vitalsigns/pdf/2013-05-vitalsigns.pdf. Accessed
July 2014. 
4. Institute of Medicine. Hepatitis and Liver Cancer: A National
Strategy for Prevention of Hepatitis B and C. Washington, DC:
National Academies Press; 2010. 
5. World Health Organization. Hepatitis C Fact Sheet. 2014.
http://www.who.int/mediacentre/factsheets/fs164/en/. Accessed July
2014. 
6. Centers for Disease Control and Prevention. Hepatitis C: General
Information. 2010.
http://www.cdc.gov/hepatitis/HCV/PDFs/HepCGeneralFactSheet.pdf.
Accessed July 2014.  
7. American Trucking Associations. Reports, Trends and Statistics.
http://www.truckline.com/News_and_Information_Reports_Industry_Data.aspx.
Accessed August 2014. 
8. Valway, S DMD, MPH, et al. Risk Assessment and Screening for
Sexually Transmitted Infections, HIV, and Hepatitis Virus Among
Long-Distance Truck Drivers in New Mexico, 2004-2006. American
Journal of Public Health 2009;99
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2759793/ 
Contact: 
Diana Van Leuven
Media Contact for Rolling Strong and HTAA
Van Leuven Communications
Phone: (800) 520-1834 x1
E-Mail: diana@vanleuvencommunications.com  
Krystal Loewe
AbbVie 
224-214-2039
krystal.loewe@abbvie.com  
Jennifer Moritz
Zer0 to 5ive for OraSure Technologies
917-748-4006
jmoritz@0to5.com 
 
 
Press spacebar to pause and continue. Press esc to stop.